Tikvah Management’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5M | Hold |
2,460,833
| – | – | 4.02% | 7 |
|
|
2025
Q1 | $7.43M | Hold |
2,460,833
| – | – | 2.53% | 13 |
|
|
2024
Q4 | $8.91M | Hold |
2,460,833
| – | – | 2.43% | 16 |
|
|
2024
Q3 | $4.33M | Hold |
2,460,833
| – | – | 1.34% | 17 |
|
|
2024
Q2 | $3.84M | Hold |
2,460,833
| – | – | 1.25% | 17 |
|
|
2024
Q1 | $4.8M | Hold |
2,460,833
| – | – | 1.5% | 16 |
|
|
2023
Q4 | $3.47M | Hold |
2,460,833
| – | – | 1.19% | 16 |
|
|
2023
Q3 | $3.89M | Hold |
2,460,833
| – | – | 1.39% | 17 |
|
|
2023
Q2 | $5.32M | Hold |
2,460,833
| – | – | 1.81% | 13 |
|
|
2023
Q1 | $5.17M | Buy |
2,460,833
+1,110,000
| +82% | +$2.33M | 2.12% | 13 |
|
|
2022
Q4 | $2.96M | Hold |
1,350,833
| – | – | 1.41% | 14 |
|
|
2022
Q3 | $4.05M | Hold |
1,350,833
| – | – | 1.87% | 12 |
|
|
2022
Q2 | $3.82M | Hold |
1,350,833
| – | – | 1.65% | 16 |
|
|
2022
Q1 | $7.23M | Buy |
1,350,833
+125,000
| +10% | +$669K | 2.31% | 12 |
|
|
2021
Q4 | $9.16M | Buy |
+1,225,833
| New | +$9.16M | 2.55% | 12 |
|